Dose dependent effects on cell cycle checkpoints and DNA repair by bendamustine

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Beeharry, Neil ^a   Rattner, Jerome B ^b   Bellacosa, Alfonso ^a   Smith, Mitchell R ^a   Yen, Timothy J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENDAMUSTINE; CHECKPOINT KINASE 1; DNA;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL VIABILITY; CHROMOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; DRUG MECHANISM; ELECTRON MICROSCOPY; EXCISION REPAIR; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; METAPHASE; MITOSIS; NONHUMAN;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL DEATH; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MICE; MITOSIS; NITROGEN MUSTARD COMPOUNDS; PROTEIN KINASES;

EID: 84863098001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040342     Document Type: Article

References (22)

1. Heider A, Niederle N, (2001) Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas. Anticancer Drugs 12: 725-9.
2. Hartley JA, Leoni LM, (2011) Mechanism of Action: The Unique Pattern of Bendamustine-Induced Cytotoxicity. Seminars in Hematology 48: S12-S23.
3. Leoni LM, Bailey B, Reifert J, Bendall HH, Zeller RW, et al. (2008) Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents. Clin Cancer Res 14: 309-17.
4. Roue G, Lopez-Guerra M, Milpied P, Perez-Galan P, Villamor N, et al. (2008) Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling. Clin Cancer Res 14: 6907-15.
5. Schwanen C, Hecker T, Hubinger G, Wolfle M, Rittgen W, et al. (2002) In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia. Leukemia 16: 2096-105.
6. Gaul L, Mandl-Weber S, Baumann P, Emmerich B, Schmidmaier R, (2008) Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways. J Cancer Res Clin Oncol 134: 245-53.
7. Cortellino S, Xu JF, Sannai M, Moore R, Caretti E, et al. (2011) Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair. Cell 146: 67-79.
8. Henegariu O, Heerema NA, Lowe Wright L, Bray-Ward P, Ward DC, et al. (2001) Improvements in cytogenetic slide preparation: controlled chromosome spreading, chemical aging and gradual denaturing. Cytometry 43: 101-9.
9. Rattner JB, Wang T, (1992) Kinetochore formation and behaviour following premature chromosome condensation. J Cell Sci 103 (Pt 4): 1039-45.
10. Feng J, Huang H, Yen TJ, (2006) CENP-F is a novel microtubule-binding protein that is essential for kinetochore attachments and affects the duration of the mitotic checkpoint delay. Chromosoma 115: 320-9.
11. Strumberg D, Harstrick A, Doll K, Hoffmann B, Seeber S, (1996) Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines. Anticancer Drugs 7: 415-21.
12. Konstantinov SM, Kostovski A, Topashka-Ancheva M, Genova M, Berger MR, (2002) Cytotoxic efficacy of bendamustine in human leukemia and breast cancer cell lines. J Cancer Res Clin Oncol 128: 271-8.
13. Liuzzi M, Talpaertborle M, (1985) A New Approach to the Study of the Base-Excision Repair Pathway Using Methoxyamine. J Biol Chem 260: 5252-8.
14. Cortazar D, Kunz C, Saito Y, Steinacher R, Schar P, (2007) The enigmatic thymine DNA glycosylase. DNA Repair (Amst) 6: 489-504.
15. Owen JS, Melhem M, Passarell JA, D'Andrea D, Darwish M, et al. (2010) Bendamustine pharmacokinetic profile and exposure-response relationships in patients with indolent non-Hodgkin's lymphoma. Cancer Chemother Pharmacol 66: 1039-49.
16. Ogura M, Ando K, Taniwaki M, Watanabe T, Uchida T, et al. (2011) Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Cancer Sci 102: 1687-92.
17. Stevens JB, Abdallah BY, Regan SM, Liu G, Bremer SW, et al. (2010) Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation. Mol Cytogenet 3: 20.
18. Johnson RT, Rao PN, (1970) Mammalian cell fusion: induction of premature chromosome condensation in interphase nuclei. Nature 226: 717-22.
19. Ogura M, Uchida T, Taniwaki M, Ando K, Watanabe T, et al. (2010) Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Cancer Sci 101: 2054-8.
20. Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, et al. (1999) Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59: 4375-82.
21. Bellacosa A, (2001) Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ 8: 1076-92.
22. Blasina A, Hallin J, Chen E, Arango ME, Kraynov E, et al. (2008) Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. Mol Cancer Ther 7: 2394-404.